Prospective, randomized, blinded, comparative study of injectable micronized dehydrated amniotic/chorionic membrane allograft for plantar fasciitis - A feasibility study

Foot and Ankle International

Volumn 34, Issue 10, 2013, Pages 1332-1339

  Zelen, Charles M ^a   Poka, Attila ^b   Andrews, James ^c  

^a Professional Education and Research Institute   (United States)

^b Orthopeadic Trauma Services   (United States)

^c Andrews Sports Medicine and Orthopaedic Center   (United States)

Author keywords

allografts; amniotic membrane; heel pain; micronized dehydrated human amniotic chorionic membrane; plantar fasciitis

Indexed keywords

BIOMATERIAL; MICRONIZED DEHYDRATED HUMAN AMNIOTIC CHORIONIC MEMBRANE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; ADVERSE OUTCOME; ALLOGRAFT; AMNION; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; PLANTAR FASCIITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT RESPONSE;

ALLOGRAFTS; AMNIOTIC MEMBRANE; HEEL PAIN; MICRONIZED DEHYDRATED HUMAN AMNIOTIC CHORIONIC MEMBRANE; PLANTAR FASCIITIS;

ALLOGRAFTS; ANESTHETICS, LOCAL; BIOLOGICAL DRESSINGS; BUPIVACAINE; CHRONIC DISEASE; FASCIITIS, PLANTAR; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SESQUITERPENES; STANDARD OF CARE; TREATMENT OUTCOME;

EID: 84885147148     PISSN: 10711007     EISSN: 19447876     Source Type: Journal    
DOI: 10.1177/1071100713502179     Document Type: Article

References (24)

1. Adly OA, Moghazy AM, Abbas AH, et al. Assessment of amniotic and polyurethane membrane dressings in the treatment of burns. Burns. 2010 ; 36 (5). 703-710
2. Bader L, Park K, Gu Y, O'Malley M. Functional outcome of endoscopic plantar facsiotomy. Foot Ankle Int. 2012 ; 33 (1). 37-43
3. Baradaran-Rafii A, Aghayan H, Arjmand B, et al. Amniotic membrane transplantation. Iran J Ophthalmic Res. 2007 ; 2 (1). 58-75
4. Bennett JP, Matthews R, Faulk WP. Treatment of chronic ulceration of the legs with human amnion. Lancet. 1980 ; 1: 1153-1156
5. Cornwall MW, McPoil TG. Plantar fasciitis: etiology and treatment. J Orthop Sports Phys Ther. 1999 ; 29: 756-760
6. Díaz-Llopis IV, Rodríguez-Ruíz CM, Mulet-Perry S, et al. Randomized controlled study of the efficacy of the injection of botulinum toxin type A versus corticosteroids in chronic plantar fasciitis: results at one and six months. Clin Rehabil. 2012 ; 26 (7). 594-606
7. Elizondo-Rodriguez J, Araujo-Lopez Y, Moreno-Gonzalez JA, et al. A comparison of botulinum toxin a and intralesional steroids for the treatment of plantar fasciitis: a randomized, double-blinded study. Foot Ankle Int. 2013 ; 34 (1). 8-14
8. Fetterolf DE, Snyder RJ. Scientific and clinical support for the use of dehydrated amniotic membrane in wound management. Wounds. 2012 ; 24 (10). 299-307
9. Goff JD, Crawford R. Diagnosis and treatment of plantar fasciitis. Am Fam Physician. 2011 ; 84: 676-682
10. Gupta SK. Intention-to-treat concept: a review. Perspect Clin Res. 2011 ; 2 (3). 109-112
11. John T. Human amniotic membrane transplantation: past, present, and future. Ophthalmol Clin North Am. 2003 ; 16: 43-65
12. Kitaoka HB, Alexander IJ, Adelaar RS, et al. Clinical rating systems for the ankle-hindfoot, midfoot, hallux and lesser toes. Foot Ankle Int. 1994 ; 15: 349-353
13. Lemont H, Ammirati KM, Usen N. Plantar fasciitis: a degenerative process (fasciosis) without inflammation. J Am Podiatr Med Assoc. 2003 ; 93: 234-237
14. Lynch SE, Nixon JC, Colvin RB, et al. Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. Proc Natl Acad Sci USA. 1987 ; 84: 7696-7700
15. Niknejad H, Peirovi H, Jorjani M, et al. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater. 2008 ; 15: 88-99
16. Parolini O, Solomon A, Evangelista M, Soncini M Human Placenta: Structure and Development. E Berven, ed. Hauppauge, NY: Nova Science ; 2010: 1-48.
17. PeerboomsJCvan LaarWFaberF, et al. Use of platelet rich plasma to treat plantar fasciitis: design of a multi centre randomized controlled trial. BMC Musculoskelet Disord. 2010;11:69. http://www.biomedcentral.com/1471-2474/11/69.
18. Riddle DL, Schappert SM. Volume of ambulatory care visits and patterns of care for patients diagnosed with plantar fasciitis: a national study of medical doctors. Foot Ankle Int. 2004 ; 25: 303-310
19. Scioli M. Platelet-rich plasma injection for proximal plantar fasciitis. Tech Foot Ankle Surg. 2011 ; 1: 7-10
20. Singh D, Angel J, Bentley G, et al. Fortnightly review. Plantar fasciitis. BMJ. 1997 ; 315: 172-175
21. Tao H, Fan H. Implantation of amniotic membrane to reduce postlaminectomy epidural adhesions. Eur Spine J. 2009 ; 18 (8). 1202-1212
22. Tatli YZ, Kapasi S. The real risks of steroid injection for plantar fasciitis, with a review of conservative therapies. Curr Rev Musculoskelet Med. 2009 ; 2: 3-9
23. Thomas JL, Christensen JC, Kravitz SR, et al. The diagnosis and treatment of heel pain: a clinical practice guideline revision 2010. J Foot Ankle Surg. 2010 ; 49: S1 - S19
24. Tong KB, Furia J. Economic burden of plantar fasciitis treatment in the United States. Am J Orthop. 2010 ; 39 (5). 227-231